Lakefront Biotherapeutics reported revenue of $0.01B and net income of $0.00B for the quarter ended Jun 2026, down 80.9% year over year. This income statement covers 45 quarters of results from Dec 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2013 | Apr2014 | Dec2014 | Dec2015 | Mar2016 | Jun2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||||||||||||||||||
| Revenue | 0.37B | -0.10B | 0.15B | 0.15B | 0.14B | -0.17B | 0.06B | 0.07B | 0.07B | 0.59B | 0.07B | -0.03B | 0.18B | 0.04B | 0.08B | 0.07B | 0.08B | 1.05B | 0.01B | 0.01B | |||||||||||||||||||||||||
| Cost of RevenueCost of Rev | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B | 0.02B | 0.00B | -0.00B | 0.02B | 0.00B | 0.01B | 0.01B | 0.01B | 34.58B | 0.01B | 0.01B | |||||||||||||||||||||||||
| Gross Profit | 0.37B | -0.10B | 0.15B | 0.14B | 0.13B | -0.18B | 0.06B | 0.06B | 0.06B | 0.57B | 0.07B | -0.03B | 0.16B | 0.04B | 0.06B | 0.07B | 0.07B | -33.53B | 0.00B | 0.00B | |||||||||||||||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | -0.11B | -274.89B | -0.06B | -259.44B | -0.08B | 0.06B | -0.25B | -358.22B | -0.19B | 0.19B | -0.40B | -534.38B | -0.04B | ||||||||||||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | -0.04B | -0.04B | -0.03B | -0.05B | -0.03B | 0.03B | -0.09B | -125.20B | -0.04B | 0.04B | -0.12B | -171.38B | -0.04B | ||||||||||||||||||||||||||||||||
| Restructuring CostsRestructuring | |||||||||||||||||||||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | 0.04B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | -0.01B | 0.03B | 0.06B | 0.01B | 0.01B | 0.43B | 705.63B | 0.00B | 0.00B | |||||||||||||||||||||||||
| Operating ExpensesOpex | -0.15B | -274.93B | -0.06B | -0.06B | -0.06B | -0.20B | -0.08B | -0.08B | -0.10B | -0.01B | -0.19B | -0.11B | -0.09B | -0.13B | -0.04B | -0.03B | |||||||||||||||||||||||||||||
| Operating IncomeOp. Inc | -0.21B | 0.00B | -0.02B | -0.08B | -0.04B | 0.00B | -0.02B | -0.01B | -0.02B | 0.23B | -0.04B | 0.11B | -0.21B | 0.08B | -0.17B | -0.06B | -0.29B | 0.88B | -0.07B | -0.05B | |||||||||||||||||||||||||
| EBIT | -0.21B | 0.00B | -0.02B | -0.08B | -0.04B | 0.00B | -0.02B | -0.01B | -0.02B | 0.23B | -0.04B | 0.11B | -0.21B | 0.08B | -0.17B | -0.06B | -0.29B | 0.88B | -0.07B | -0.05B | |||||||||||||||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | -0.00B | -10.04B | -0.00B | -2.81B | -0.00B | 0.00B | -0.00B | -1.78B | -0.00B | -0.00B | -0.00B | -3.33B | -0.00B | ||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | |||||||||||||||||||||||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.04B | -0.08B | -0.00B | -0.00B | 0.00B | 0.01B | 0.01B | 0.02B | 0.02B | 0.03B | 0.03B | 0.03B | 0.03B | 0.02B | 0.01B | 0.01B | 0.01B | 0.02B | |||||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | |||||||||||||||||||||||||||||||||||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||||||||||||||
| EBT | -0.21B | 0.00B | -0.01B | -0.08B | -0.04B | -72.28B | -0.01B | -0.01B | -0.02B | 6.00B | 0.02B | 0.05B | -0.10B | -3.27B | -0.16B | 0.18B | -0.56B | 350.79B | 0.02B | -0.05B | |||||||||||||||||||||||||
| Tax ProvisionsTaxes | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.58B | 0.00B | -0.01B | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | 0.02B | 21.65B | -0.00B | -0.00B | |||||||||||||||||||||||||
| Profit After TaxPAT | -0.14B | -0.06B | -0.01B | -0.02B | 0.02B | -0.21B | 0.02B | -0.03B | 0.07B | 227.72B | 0.10B | -0.02B | -0.02B | 79.11B | -0.16B | -0.12B | -0.24B | 374.06B | 0.02B | 0.00B | |||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -0.21B | 0.01B | -0.01B | -0.08B | -0.04B | -71.70B | -0.01B | -0.00B | -0.02B | 6.00B | 0.02B | 0.05B | -0.10B | -3.27B | -0.17B | 0.18B | -0.58B | 329.14B | 0.02B | -0.05B | |||||||||||||||||||||||||
| Income from Discontinued OperationsIncome (Discontinued) | 0.03B | -0.01B | 0.04B | 0.00B | -0.02B | 0.21B | 0.07B | 0.00B | -0.00B | 80.46B | 0.00B | -0.00B | 0.00B | 1.62B | 0.00B | 0.00B | |||||||||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -0.18B | 0.00B | -0.01B | -0.08B | -0.04B | -71.70B | 0.02B | 0.00B | -0.04B | 6.22B | 0.10B | 0.06B | -0.11B | 77.19B | -0.17B | 0.18B | -0.58B | 330.75B | 0.02B | -0.05B | |||||||||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -0.18B | -0.06B | -0.01B | -0.02B | 0.02B | 0.23B | 0.02B | 0.00B | -0.04B | 227.72B | 0.10B | 0.06B | -0.11B | 79.11B | -0.16B | 0.18B | -0.58B | 374.06B | 0.02B | -0.05B | |||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -0.18B | -0.06B | -0.01B | -0.02B | 0.02B | 0.23B | 0.02B | 0.00B | -0.04B | 227.72B | 0.10B | 0.06B | -0.11B | 79.11B | -0.16B | 0.18B | -0.58B | 374.06B | 0.02B | -0.05B | |||||||||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -2.79 | -0.96 | -0.23 | -0.31 | 0.33 | 3.55 | 0.38 | 0.01 | -0.54 | 0.00B | 1.49 | 0.87 | -1.62 | 0.00B | -2.45 | 2.67 | -8.84 | 0.00B | 0.26 | -0.76 | |||||||||||||||||||||||||
| EPS (Diluted) | -2.68 | -0.48 | -0.11 | -0.15 | 0.17 | 3.55 | 0.38 | 0.01 | -0.54 | 0.00B | 1.49 | 0.87 | -1.61 | 0.00B | -2.45 | 2.67 | -8.84 | 0.00B | 0.26 | -0.76 | |||||||||||||||||||||||||
| Shares Outstanding | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | |||||||||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.07B | 0.13B | 0.13B | 0.13B | 0.13B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | |||||||||||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | ||||||||||||||||||||||||||||||||||||||||
| EBITDA | -0.21B | 0.00B | -0.02B | -0.08B | -0.04B | 0.00B | -0.02B | -0.01B | -0.02B | 0.23B | -0.04B | 0.11B | -0.21B | 0.08B | -0.17B | -0.06B | -0.29B | 0.88B | -0.07B | -0.05B | |||||||||||||||||||||||||
| Interest ExpensesInt Expense | -0.00B | -10.04B | -0.00B | -2.81B | -0.00B | 0.00B | -0.00B | -1.78B | -0.00B | -0.00B | -0.00B | -3.33B | -0.00B | ||||||||||||||||||||||||||||||||
| Tax Rate | -0.17% | -40.88% | 14.88% | 1.02% | 1.94% | 0.80% | -1.63% | 95.43% | -3.81% | -0.04% | 2.48% | -1.38% | -1.94% | 0.00% | -1.16% | -0.07% | -3.64% | 6.17% | -0.50% | 0.30% |